Bluesky Facebook Reddit Email

New study: abatacept therapy offers promising results treating juvenile dermatomyositis

03.08.23 | George Washington University

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

This release has been removed per the request of the submitting institution. Please contact Rachel Larris, rlarris@gwu.edu, for more information.

Arthritis & Rheumatology

Randomized controlled/clinical trial

People

Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy

19-Jan-2023

Keywords

Article Information

Contact Information

Rachel Larris
George Washington University
rlarris@gwu.edu

How to Cite This Article

APA:
George Washington University. (2023, March 8). New study: abatacept therapy offers promising results treating juvenile dermatomyositis. Brightsurf News. https://www.brightsurf.com/news/19NZ2P91/new-study-abatacept-therapy-offers-promising-results-treating-juvenile-dermatomyositis.html
MLA:
"New study: abatacept therapy offers promising results treating juvenile dermatomyositis." Brightsurf News, Mar. 8 2023, https://www.brightsurf.com/news/19NZ2P91/new-study-abatacept-therapy-offers-promising-results-treating-juvenile-dermatomyositis.html.